UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer therapy in China: Introducing the Special Collection

Cancer, 2024-04, Vol.130 (S8), p.1368-1370

2024

Volltextzugriff (PDF)

Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

Journal of the American Chemical Society, 2008-07, Vol.130 (28), p.9006-9012

2008

Volltextzugriff (PDF)

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Cancer, 2021-09, Vol.127 (18), p.3302-3309

2021

Volltextzugriff (PDF)

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

Cancer, 2020-08, Vol.126 (15), p.3400-3416

2020

Volltextzugriff (PDF)

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers

Breast cancer research and treatment, 2012-08, Vol.135 (1), p.39-48

2012

Volltextzugriff (PDF)

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Cancer, 2018-12, Vol.124 (24), p.4618-4621

2018

Volltextzugriff (PDF)

Targeting forkhead box M1 transcription factor in breast cancer

Biochemical pharmacology, 2018-08, Vol.154, p.407-413

2018

Volltextzugriff (PDF)

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Cancer, 2023-01, Vol.129 (2), p.171-174

2023

Volltextzugriff (PDF)

Progress in breast cancer research amid the COVID‐19 gloom

Cancer, 2020-08, Vol.126 (S16), p.3809-3810

2020

Volltextzugriff (PDF)

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

Cancer, 2019-01, Vol.125 (2), p.177-180

2019

Volltextzugriff (PDF)

The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer

Cancers, 2023-08, Vol.15 (15), p.3957

2023

Volltextzugriff (PDF)

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer

Molecular cancer therapeutics, 2021-12, Vol.20 (12), p.2553-2567

2021

Volltextzugriff (PDF)

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

Breast cancer research and treatment, 2009-01, Vol.113 (2), p.357-370

2009

Volltextzugriff (PDF)

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.5045-5056

2014

Volltextzugriff (PDF)

Emerging use of nanoparticles in diagnosis and treatment of breast cancer

The lancet oncology, 2006-08, Vol.7 (8), p.657-667

2006

Volltextzugriff (PDF)

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9712-9722

2008

Volltextzugriff (PDF)

Creating the High School Pipeline for Future Deaf Scientists in Academic Medicine

Academic medicine, 2023-11, Vol.98 (11), p.1235-1235

2023

Volltextzugriff (PDF)

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy

Breast cancer research and treatment, 2020-10, Vol.183 (3), p.617-627

2020

Volltextzugriff (PDF)

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (5), p.982-993

2019

Volltextzugriff (PDF)

Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

Breast cancer research and treatment, 2010-08, Vol.123 (1), p.139-147

2010

Volltextzugriff (PDF)

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Volltextzugriff (PDF)

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

Cancer, 2015-02, Vol.121 (4), p.517-526

2015

Volltextzugriff (PDF)

Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling

Cancers, 2019-12, Vol.11 (12), p.2039

2019

Volltextzugriff (PDF)

Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma

Journal of proteome research, 2008-04, Vol.7 (4), p.1470-1480

2008

Volltextzugriff (PDF)

A phenocopy signature of TP53 loss predicts response to chemotherapy

NPJ precision oncology, 2024-10, Vol.8 (1), p.220-10, Article 220

2024

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Englisch
(146)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Breast cancer therapy in China: Introducing the Special Collection

Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Targeting forkhead box M1 transcription factor in breast cancer

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Progress in breast cancer research amid the COVID‐19 gloom

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Emerging use of nanoparticles in diagnosis and treatment of breast cancer

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Creating the High School Pipeline for Future Deaf Scientists in Academic Medicine

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling

Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma

A phenocopy signature of TP53 loss predicts response to chemotherapy

Suchergebnisse filtern